Health Affairs September 15, 2024
Clifford E. Douglas, J.D., Chief Executive Officer

Like most people, I’m uncomfortable having to say these three simple words: “I was wrong.”

But six years ago, while serving as the national vice president for tobacco control at the American Cancer Society, I found myself saying just that. I had led an intensive process of analysis featuring input from dozens of scientific experts that led me to realize I was incorrect about a core principle of my commitment to reducing the death and disease related to smoking.

With new evidence at our disposal, it became clear that reduced-risk nicotine products like e-cigarettes, nicotine pouches, the smokeless tobacco product called snus, and heated tobacco devices have a place in helping adults who smoke to stop, alongside traditional medicinal therapies....

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Healthcare System, Public Health / COVID
Transforming public health: a physician’s innovative approach [PODCAST]
Trump Nominates Physicians for CDC Director, Surgeon General
5 Things You Should Know About Long COVID
Q&A: How school eligibility influences the spread of infectious diseases
The surprising effect COVID-19 could have on cancer

Share This Article